Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Chloral hydrate °æ±¸Åõ¿©ÀÇ ÁøÁ¤È¿°ú°¡ ³ªÅ¸³ªÁö ¾Ê´Â ¼Ò¾ÆȯÀÚ¿¡ ´ëÇÑ MidazolamÀÇ ºñ°­³» Ãß°¡ Åõ¿©

The Sedative Effect Of Intranasal Midazolam Additionally Administered To Children Who Fail To Respond Properly To Oral Chloral Hydrate.

´ëÇѼҾÆÄ¡°úÇÐȸÁö 1997³â 24±Ç 3È£ p.537 ~ 542
À¯º´±Ô, ¹Ú¿ë¼±, ÃÖ¿ëö,
¼Ò¼Ó »ó¼¼Á¤º¸
À¯º´±Ô (  ) - ´Ü±¹´ëÇб³ Ä¡°ú´ëÇÐ ¼Ò¾ÆÄ¡°úÇб³½Ç
¹Ú¿ë¼± (  ) - ´Ü±¹´ëÇб³ Ä¡°ú´ëÇÐ ¼Ò¾ÆÄ¡°úÇб³½Ç
ÃÖ¿ëö (  ) - ´Ü±¹´ëÇб³ Ä¡°ú´ëÇÐ ¼Ò¾ÆÄ¡°úÇб³½Ç

Abstract

°á·Ð
Chloral hydrate °æ±¸ Åõ¿©ÀÇ È¿°ú°¡ ³ªÅ¸³ªÁö ¾Ê´Â ¼Ò¾Æ ȯÀÚ¿¡ MidazolamÀ» ºñ°­³»·Î
Ãß°¡ Åõ¿©ÇÏ¿© ¾Æ·¡¿Í °°Àº °á·ÐÀ» ¾ò¾ú´Ù.
1. Chloral hydrate °æ±¸ Åõ¿©ÀÇ È¿°ú°¡ ³ªÅ¸³ªÁö ¾Ê¾Æ Ä¡·á°¡ ¾î·Á¿î »óȲÀÇ Áõ·Ê¿¡
Midazolam¸¦ ºñ°­³»·Î Ãß°¡ Åõ¿©ÇÑ °á°ú, 69.4%ÀÇ Áõ·Ê¿¡¼­´Â ¾Æ¹« ¾î·Á¿ò ¾øÀÌ Ä¡·á¸¦ ¿Ï
·áÇÒ ¼ö ÀÖ¾úÀ¸¸ç 23.8% ¿ª½Ã ´Ù¼ÒÀÇ ¾î·Á¿òÀº ÀÖ¾úÀ¸³ª Ä¡·á°¡ ¿Ï·áµÊÀ¸·Î½á ÃÑ 93.2%ÀÇ
Áõ·Ê¿¡¼­ Ä¡·á°¡ ¿Ï·áµÈ °á°ú¸¦ ¾ò¾ú´Ù.
2. ÀÌ»óÀÇ °á°ú´Â ȯÀÚ¿Í È¯ÀÚ º¸È£ÀÚ¿¡°Ô »ó´çÇÑ ¸¸Á·°¨À» ÁØ °ÍÀ¸·Î Æò°¡µÇ¾ú´Ù.
3. µ¿ÀÏÇÑ È¯ÀÚ ³»¿¡¼­µµ ÁøÁ¤ È¿°úÀÇ º¯ÀÌ°¡ ´Ù¼Ò Å« °æ¿ìµµ ÀÖ¾úÀ¸¹Ç·Î º¸´Ù ¸¹Àº ȯÀÚ¸¦
´ë»óÀ¸·Î ÇÑ ¿¬±¸°¡ ¿ä±¸µÈ´Ù.
#ÃÊ·Ï#
Chloral hydrate is one of the most widely used sedative to control the difficult-to-treat
young age group in the dental clinic. The normal onset time of oral Chloral hydrate is
3-45 minute with some variations. We are often frustrated see the patient still awake
and cry with agitation even after far more than the normal onset time. In such a case,
the patient has to be rescheduled for another sedation visit with different a sedative
regimen that can possibly help the clinician complete scheduled treatment without
postponement. We have tried additional administration of Midazolam intranasally to 22
patients of those who failed to respond properly to the initial dose(50-75mg/kg) of oral
Chloral hydrate. The average age and weight of the patients was 34.2 months(22-61
mos.) and 15.2kg(10-17kg) respectively. Half of the regular dose of Midazolam(0.1mg/kg)
was administered intranasally using needless syringe in 42 cases without notable
resistance of the patient. The onset was very rapid in most cases and could proceed the
treatment under the constant monitoring by Pulse oximeter. All the planned procedures
could be completed in 93.2%(69.4% of 'Good' plus 23.8% of 'Fair' rating) with only
6.8%('Poor' rating) of failure rate. Evidence of adverse effect was not detected or
reported during and/or after the procedures

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI